Application of Medicinal Plants to Cure Mental Disorders

Year : 2024 | Volume :14 | Issue : 01 | Page : 69-78

Sankalp Tikku

Uday Kapur

Pankaj Kumar Tripathi

Chakresh Kumar Jain

  1. Student Department of Biotechnology, Jaypee Institute of Information Technology, Noida Uttar Pradesh India
  2. Student Department of Biotechnology, Jaypee Institute of Information Technology, Noida Uttar Pradesh India
  3. Research Scholar Department of Biotechnology, Jaypee Institute of Information Technology, Noida Uttar Pradesh India
  4. Associate Professor Department of Biotechnology, Jaypee Institute of Information Technology, Noida Uttar Pradesh India


Mental fitness is a state of well-being in which individuals apprehend their talents, manage existing pressures, remain efficient, and contribute to their groups. Mental contamination regularly used interchangeably with intellectual illness, is vital to apprehending and addressing man or woman desires and challenges. Schizophrenia, a psychological disorder characterized by hallucinations and delusions, is a complex situation with two important classes: bad symptoms (withdrawal from social interactions, loss of force, and unresponsive emotional country) and high-quality signs and symptoms (hallucinations, delusions, and disordered thoughts). India has a large and diversified population, which contributes to a significant mental health burden that needs immediate treatment. Mental health illnesses af ect people from all walks of life and transcend age, financial status, and geographic location. These disorders have a wide range of consequences, including increased society expenses, diminished everyday functioning, and personal misery. The increasing public health concern is a result of the steady growth in the prevalence of mental health diseases in India in recent years. It is estimated that around 15% of Indians suffer from mental health problems. Numerous conditions are included in this figure, such as substance use disorders, anxiety disorders, depression, bipolar disorder, schizophrenia, and neurodevelopmental disorders. Medicinal plants have vast potential in healthcare worldwide, mainly in growing international locations where 70-80% of people depend on traditional medication for primary healthcare wishes. These flowers of er a desire for novel remedies for drug-resistant diseases and ailments left unaddressed by mainstream prescription medications. Traditional healers have used several plant life with validated healing blessings, consisting of natural remedies incorporated into psychiatry for intellectual ailments like schizophrenia. Phytochemicals determined in vegetation can enhance the features of diverse human organs, preventing many diseases. Many traditional medicinal herbs and their components have healing properties and may be used to save you, deal with, or cure diverse human sicknesses.

Keywords: Medicinal Plants, Mental Disorders, Antipsychotic plants, Depression, Anxiety, Schizophrenia, Epilepsy, Neuralgia

[This article belongs to Research & Reviews : A Journal of Biotechnology(rrjobt)]

How to cite this article: Sankalp Tikku, Uday Kapur, Pankaj Kumar Tripathi, Chakresh Kumar Jain. Application of Medicinal Plants to Cure Mental Disorders. Research & Reviews : A Journal of Biotechnology. 2024; 14(01):69-78.
How to cite this URL: Sankalp Tikku, Uday Kapur, Pankaj Kumar Tripathi, Chakresh Kumar Jain. Application of Medicinal Plants to Cure Mental Disorders. Research & Reviews : A Journal of Biotechnology. 2024; 14(01):69-78. Available from:


  1. Aljunaidy MM, Adi MN. Architecture and Mental Disorders: A Systematic Study of Peer-Reviewed Literature. HERD 2020;320–330.
  2. Hernández-Torrano D, Ibrayeva L, Sparks J, Lim N, Clementi A, Almukhambetova A, et al. Mental Health and Well-Being of University Students: A Bibliometric Mapping of the Literature. Frontiers in Psychology 2020;11.
  3. Organization Depression and Other Common Mental Disorders: Global Health Estimates. 2022.
  4. Allen N. Book Review: Cognitive Therapy of Depression. Australian and New Zealand Journal of Psychiatry 2002;275–278.
  5. Ellsworth PD. Diagnostic and Statistical Manual of Mental Disorder. ˜The œAmerican Journal of Occupational Therapy 1980;819.
  6. Belmaker RH, Agam Major Depressive Disorder. New England Journal of Medicine/˜The œNew England Journal of Medicine 2008;55–68.
  7. Eylem Ö, De Wit L, Van Straten A, Steubl L, Melissourgaki Z, Danışman GT, et al. Stigma for common mental disorders in racial minorities and majorities a systematic review and meta-analysis. BMC Public Health 2020;20.
  8. Moshiri E, Basti AA, Noorbala A-A, Jamshidi AH, Abbasi SH, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: A double-blind, randomized and placebo-controlled Phytomedicine 2006;607–611.
  9. Akhondzadeh S, Tahmacebi-Pour N, Noorbala A-A, Amini H, Fallah-Pour H, Jamshidi AH, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double‐blind, randomized and placebo‐controlled trial. PTR Phytotherapy Research/Phytotherapy Research 2005;148–151.
  10. Basti AA, Moshiri E, Noorbala A-A, Jamshidi AH, Abbasi SH, Akhondzadeh S. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007;439–442.
  11. Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]. BMC Complementary and Alternative Medicine 2004;4.
  12. Noorbala A-A, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Journal of Ethnopharmacology 2005;281–284.
  13. Hausenblas HA, Saha D, Dubyak PJ, Anton SD. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Journal of Integrative Medicine/Journal of Integrative Medicine 2013;377–383.
  14. Lopresti AL, Drummond PD. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology 2014;517–527.
  15. Mazidi M, Shemshian M, Mousavi SH, Norouzy A, Kermani T, Moghiman T, et A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression. Journal of Complementary & Integrative Medicine/Journal of Complementary and Integrative Medicine 2016;195–199.
  16. Teschke R, Gaus W, Loew Kava extracts: Safety and risks including rare hepatotoxicity. Phytomedicine (Stuttgart) 2003;440–446.
  17. Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, et al. Hepatotoxicity Induced by “the 3Ks”: Kava, Kratom and Khat. International Journal of Molecular Sciences 2016;580.
  18. Abolhassani M. Clinical research Antiviral activity of borage (Echium amoenum). Archives of Medical Science/Archives of Medical Science (Online) 2010;366–369.
  19. Sayyah M, Sayyah M, Kamalinejad M. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006;166–169.
  20. D K, Suresh K. Screening of Antianxiety Activity of Abies pindrow Royle Aerial Indian Journal of Pharmaceutical Education and Research 2015.
  21. Anita R, Chander M. Pharmacological and Phytochemical Evaluation of Calendula officinalis For Anti-Anxiety Activity. International Journal of Pharmacognosy and Phytochemical Research 2017;9.
  22. Kaur D, Shri R, Kamboj Evaluation of Anti-Anxiety Effect of Brassica oleracea L. Extracts in Experimental Animals. Pharmacognosy Journal 2017;638–643.
  23. Schizophrenia 2022.
    Schizophren ia%20affects%20approximately%2024%20million,as%20many%20other%20mental
  24. Charlson FJ, Ferrari AJ, Santomauro D, Diminic S, Stockings E, Scott JG, et al. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016. Schizophrenia Bulletin 2018;1195–1203.
  25. Rajalakshmi R, Menon KN, Nair SC. Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia. Advanced Pharmaceutical Bulletin 2021;490–508.
  26. Rathbone J, Zhang L, Zhang M, Xia J, Liu X, Yang Chinese herbal medicine for schizophrenia. Cochrane Library 2005.
  27. Xiao S, Han X, Li X, Chen C, Li G, Yuan C, et A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia. Neuroscience Bulletin/Neuroscience Bulletin 2011;258–268.
  28. Deng H, Adams CE. Traditional Chinese medicine for schizophrenia: A survey of randomized Asia-Pacific Psychiatry 2016;9.
  29. Shorvon S. The causes of epilepsy: Changing concepts of etiology of epilepsy over the past 150 years. Epilepsia 2011;1033–1044.
  30. Wa Epilepsy: frequency, causes and consequences. CiNii Research 1990.
  31. Stafstrom CE, Carmant L. Seizures and Epilepsy: An Overview for Neuroscientists. Cold Spring Harbor Perspectives in Medicine 2015;a022426.
  32. Pahuja M, Mehla J, Reeta KH, Joshi S, Gupta YK. Hydroalcoholic extract of Zizyphus jujuba ameliorates seizures, oxidative stress, and cognitive impairment in experimental models of epilepsy in rats. Epilepsy & Behavior 2011;356–363.
  33. Pahuja M, Kleekal T, Reeta KH, Tripathi M, Gupta YK. Interaction profile of Zizyphus jujuba with phenytoin, phenobarbitone, and carbamazepine in maximal electroshock‐induced seizures in rats. Epilepsy & Behavior 2012;368–373.
  34. Ahmad B. DeptOZ. Distribution, morphology and medicinal uses of Taxus baccata
  35. Nisar M, Khan I, Simjee SU, Gilani AH, Obaidullah, Perveen H. Anticonvulsant, analgesic and antipyretic activities of Taxus wallichiana Zucc. Journal of Ethnopharmacology 2008;490–494.
  36. Wang S, Li X, Zhou S, Sun D-X, Wang H, Cheng P, et al. Intervention Effects of Ganoderma Lucidum Spores on Epileptiform Discharge Hippocampal Neurons and Expression of Neurotrophin-4 and N-Cadherin. PloS One 2013;e61687.
  37. Socała K, Nieoczym D, Grzywnowicz K, Stefaniuk D, Właź P. Evaluation of Anticonvulsant, Antidepressant-, and Anxiolytic-like Effects of an Aqueous Extract from Cultured Mycelia of the Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Higher Basidiomycetes) in Mice. International Journal of Medicinal Mushrooms 2015;209–218.
  38. Tello I, Campos-Peña V, Montiel E, Rodríguez V, Aguirre-Moreno A, León‐Rivera I, et al. Anticonvulsant and Neuroprotective Effects of Oligosaccharides from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes). International Journal of Medicinal Mushrooms 2013;555–568.
  39. Wang S, Li X, Qiu H, Jiang Z, Simon M, Ma X, et al. Anti-Epileptic Effect of Ganoderma Lucidum Polysaccharides by Inhibition of Intracellular Calcium Accumulation and Stimulation of Expression of CaMKII α in Epileptic Hippocampal PloS One 2014;e102161.
  40. MacLaren R, Forrest LK, Kiser TH. Adjunctive Dexmedetomidine Therapy in the Intensive Care Unit: A Retrospective Assessment of Impact on Sedative and Analgesic Requirements, Levels of Sedation and Analgesia, and Ventilatory and Hemodynamic Parameters. Pharmacotherapy 2007;351–359.
  41. Zakrzewska JM, McMillan Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain. Postgraduate Medical Journal 2011;410–416.
  42. Cruccu G, Gronseth GS, Alksne JF, Argoff CE, Brainin M, Burchiel KJ, et al. AAN‐EFNS guidelines on trigeminal neuralgia management. European Journal of Neurology 2008;1013–1028.
  43. Emril DR, Ho Treatment of trigeminal neuralgia: role of radiofrequency ablation. Journal of Pain Research 2010;249.
  44. Pollock Surgical Management of Medically Refractory Trigeminal Neuralgia. Current Neurology and Neuroscience Reports 2011;125–131.
  45. Muthuraman A, Singh N, Jaggi AS. Effect of hydroalcoholic extract of Acorus calamus on tibial and sural nerve transection-induced painful neuropathy in rats. Natural Medicines/Journal of Natural Medicines 2010;282–292.
  46. Watcho P, Stavniichuk R, Ribnicky DM, Raskin I, Obrosova IG. High-Fat Diet-Induced Neuropathy of Prediabetes and Obesity: Effect of PMI-5011, an Ethanolic Extract of Artemisia dracunculus L. Mediators of Inflammation 2010;1–10.
  47. Hong JH, Lee Effects of Artemisia capillaris ethyl acetate fraction on oxidative stress and antioxidant enzyme in high-fat diet induced obese mice. Chemico-Biological Interactions 2009;88–93.
  48. Reza SM, Mirshekari H, Saberi The Nociceptive and Anti-Inflammatory Effects ofArtemisia dracunculusL. Aqueous Extract on Fructose Fed Male Rats. Evidence-Based Complementary and Alternative Medicine 2015;1–5.
  49. Thiagarajan VRK, Shanmugam P, Krishnan UM, Muthuraman A, Singh N. Antinociceptive effect of Butea monosperma on vincristine-induced neuropathic pain model in rats. Toxicology and Industrial Health 2012;3–13.
  50. Thiagarajan VRK, Shanmugam P, Krishnan UM, Muthuraman A, Singh N. Ameliorative potential of Butea monosperma on chronic constriction injury of sciatic nerve induced neuropathic pain in rats. Anais Da Academia Brasileira de Ciências 2012;1091–1104.
  51. Zhou J, Ouédraogo M, Qu F, Duez P. Potential Genotoxicity of Traditional Chinese Medicinal Plants and Phytochemicals: An Overview. PTR Phytotherapy Research/Phytotherapy Research 2013;1745–1755.
  52. Rodrigues E, Barnes J. Pharmacovigilance of Herbal Medicines. Drug Safety 2012;1–12.
  53. Farah MH, Edwards IR, Lindquist M, Shaw D. International Monitoring of Adverse Health Effects Associated with Herbal Medicines. Pharmacoepidemiology… ResearchGate
  54. Chaudhari, Pinjari, Patil, Khandare, Salunke. Future Prospects of Medicinal Plants. International Journal of Pharmaceutical Research and Applications 2022;7:1816–22.

Regular Issue Subscription Review Article
Volume 14
Issue 01
Received March 28, 2024
Accepted April 13, 2024
Published May 9, 2024